Abstract

Extravasation is a multi-step process implicated in many physiological and pathological events. This process is essential to get leukocytes to the site of injury or infection but is also one of the main steps in the metastatic cascade in which cancer cells leave the primary tumor and migrate to target sites through the vascular route. In this perspective, extravasation is a double-edged sword. This systematic review analyzes microfluidic 3D models that have been designed to investigate the extravasation of cancer and immune cells. The purpose of this systematic review is to provide an exhaustive summary of the advanced microfluidic 3D models that have been designed to study the extravasation of cancer and immune cells, offering a perspective on the current state-of-the-art. To this end, we set the literature search cross-examining PUBMED and EMBASE databases up to January 2020 and further included non-indexed references reported in relevant reviews. The inclusion criteria were defined in agreement between all the investigators, aimed at identifying studies which investigate the extravasation process of cancer cells and/or leukocytes in microfluidic platforms. Twenty seven studies among 174 examined each step of the extravasation process exploiting 3D microfluidic devices and hence were included in our review. The analysis of the results obtained with the use of microfluidic models allowed highlighting shared features and differences in the extravasation of immune and cancer cells, in view of the setup of a common framework, that could be beneficial for the development of therapeutic approaches fostering or hindering the extravasation process.

Highlights

  • Extravasation is the process in which cells that are flowing into a vascular vessel interact with the endothelium lumen, adhere to it, and cross the endothelial barrier to reach a target site, guided by various types of stimulation

  • Extravasation is crucial during the metastatic cascade, whereby circulating cancer cells deriving from the primary tumor cross the endothelial barrier of specific organs to reach the targeted metastatic site (Reymond et al, 2013)

  • 16 studies investigated the extravasation of cancer cells only, 8 investigated the extravasation of immune cells only, and 3 studies investigated cancer and immune cell behavior in the same extravasation models

Read more

Summary

Introduction

Extravasation is the process in which cells that are flowing into a vascular vessel interact with the endothelium lumen, adhere to it, and cross the endothelial barrier to reach a target site, guided by various types of stimulation. This process represents a key step in several pathologic conditions, for this reason many researchers are focusing on trying to understand and control this phenomenon. Extravasation is crucial during the metastatic cascade, whereby circulating cancer cells deriving from the primary tumor cross the endothelial barrier of specific organs to reach the targeted metastatic site (Reymond et al, 2013). Even if the extravasation steps are essentially the same, according to the type of extravasating cells, there are differences in cell responsiveness to specific chemoattractants and diverse activation and/or expression of adhesion molecules mediating cell interactions with the endothelium (Schnoor et al, 2015)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call